Search Results
Ticagrelor 25mg 25mg | Purity Not Available
Adooq Bioscience
Ticagrelor (AZD6140) is the first reversibly binding oral P2Y(12) receptor antagonist that blocks ADP-induced platelet aggregation.
More Information Supplier PageFG-4592 50mg 50mg | Purity Not Available
Adooq Bioscience
FG-4592 is a novel hypoxia inducible factor prolyl hydroxylase inhibitor, in CKD anemia.
More Information Supplier PageFG-4592 25mg 25mg | Purity Not Available
Adooq Bioscience
FG-4592 is a novel hypoxia inducible factor prolyl hydroxylase inhibitor, in CKD anemia.
More Information Supplier PageFG-4592 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
FG-4592 is a novel hypoxia inducible factor prolyl hydroxylase inhibitor, in CKD anemia.
More Information Supplier PageFG-4592 100mg 100mg | Purity Not Available
Adooq Bioscience
FG-4592 is a novel hypoxia inducible factor prolyl hydroxylase inhibitor, in CKD anemia.
More Information Supplier PageFG-4592 10mg 10mg | Purity Not Available
Adooq Bioscience
FG-4592 is a novel hypoxia inducible factor prolyl hydroxylase inhibitor, in CKD anemia.
More Information Supplier PageTAK-285 50mg 50mg | Purity Not Available
Adooq Bioscience
TAK-285 is an investigational HER2/EGFR inhibitor that penetrates the CNS in Rats with an Intact Blood Brain Barrier (BBB).
More Information Supplier Page